InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier provider of ...
Researchers evaluated an allogeneic umbilical cord cell therapy in T1DM. A single dose provided durable insulin preservation, ...
Company announces $30 million Series A financing and founding leadership team with expertise in pulmonary drug innovation and track record ...
In every organism, the regulation of cell populations is a constant process. This balance relies on a continuous interplay ...
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have found that human hematopoietic ...
DNA can voyage along intercellular highways called tunneling nanotubes. It’s a phenomenon that could potentially spread tumor ...
The immune system exhibits remarkable plasticity, enabling dynamic responses to environmental cues while maintaining tissue homeostasis. Emerging evidence ...
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the appointment of Bijan Nejadnik, M.D., as Chief ...
Neurons, the uber-connected nerve cells that act as a main switchboard for the brain, are central to some incredibly ...
Cellular Intelligence has secured global rights to Novo Nordisk's Parkinson's program, a clinical-stage allogeneic cell ...
This cell therapy Parkinson's program is truly innovative and exemplifies the powerful convergence of exciting academic ...
Come fall, there will be no cell phone use allowed at any Davis Joint Unified campus, from early kindergarten through grade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results